Canadian health officials said on Friday data suggests reported cases of rare heart inflammation were relatively higher after Moderna’s COVID-19 vaccine compared with the Pfizer/BioNTech shots.
The data also indicated heart inflammation occurs more often in adolescents and adults under 30 years of age, and more often in males.
The statement from the Public Health Agency of Canada said the majority of the affected individuals experienced relatively mild illness and recovered quickly.
Get weekly health news
The risk of cardiac complications, including heart inflammation, has been shown to be substantially increased following COVID-19 infections, with the risks higher after the infection than after vaccination, according to the statement.
- Gas prices set to change when excise tax pause expires — what to know
- Toronto police say 2022 murder suspect who goes by ‘Jay’ linked to attempted killing
- Wholesale sales popped 9% from a year ago with all sectors up, says StatCan
- Certain Whole Foods products recalled over salmonella fears linked to U.S.
-
![]()
Dairy co-op to expand cottage cheese production to satisfy Canadians’ growing appetites -
![]()
U.S. oil company establishes operations on Greenland without consent -
![]()
Canada, U.S. trade reps meet again as Trump’s 50 per cent tariff deadline looms -
![]()
StubHub stock tumbles as soccer fans left disappointed after FIFA World Cup
The benefits of mRNA shots in preventing COVID-19 continue to outweigh the risks, regulators in the United States, EU and the World Health Organization have said.
Comments
Want to discuss? Please read our Commenting Policy first.